Get the Stockscreener App
1.62
3.85%
0.06
Bluejay Diagnostics Inc stock is traded at $1.62, with a volume of 9,708.
It is up +3.85% in the last 24 hours and up +1.25% over the past month.
Bluejay Diagnostics Inc is a medical diagnostics company. It is developing rapid tests using whole blood using its Symphony technology platform to improve patient outcomes in critical care settings. The company's first product, the Symphony IL-6 test, is for the monitoring of disease progression in critical care settings and is a clinically established inflammatory biomarker for the assessment of the severity of infection and inflammation across many disease indications, including sepsis.
See More
Previous Close:
$1.56
Open:
$1.6093
24h Volume:
9,708
Relative Volume:
0.01
Market Cap:
$2.42M
Revenue:
-
Net Income/Loss:
$-8.59M
P/E Ratio:
-0.00118
EPS:
-1373
Net Cash Flow:
$-9.25M
1W Performance:
+0.62%
1M Performance:
+1.25%
6M Performance:
-59.50%
1Y Performance:
-94.58%
1-Day Range:
$1.6093
$1.63
1-Week Range:
$1.52
$1.64
52-Week Range:
$1.46
$37.50
Bluejay Diagnostics Inc Stock (BJDX) Company Profile
Name
Bluejay Diagnostics Inc
Sector
Industry
Phone
(978) 631-0152
Address
360 MASSACHUSETTS AVENUE, SUITE 203, ACTON
Compare BJDX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BJDX
Bluejay Diagnostics Inc
|
1.62 | 2.33M | 0 | -8.59M | -9.25M | -1,373.00 |
|
ABT
Abbott Laboratories
|
125.83 | 218.75B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
107.76 | 152.62B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
400.93 | 151.01B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
92.01 | 117.43B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.91 | 44.76B | 5.54B | 4.18B | 623.10M | 7.00 |
Bluejay Diagnostics Inc Stock (BJDX) Latest News
What analysts say about Bluejay Diagnostics Inc. stockConsistently exceptional gains - Autocar Professional
Is Bluejay Diagnostics Inc. a good long term investmentRapid growth opportunities - Autocar Professional
What drives EXTR stock priceHigh-performance investment picks - jammulinksnews.com
Best Telecom Stocks to Buy in India Trending Stocks To BuyOutstanding capital growth - Autocar Professional
Bank of Maharashtra (532525) Gets Regulatory ApprovalExponential wealth increase - jammulinksnews.com
Bluejay Diagnostics Inc. Stock Analysis and ForecastExceptional stock performance - jammulinksnews.com
What drives Bluejay Diagnostics Inc. stock priceBreakthrough stock performance - jammulinksnews.com
Top Penny Stocks to Buy in India AI Driven Stock ResearchFree Stock Market Query - Autocar Professional
WING Stock Analysis and ForecastSuperior capital gains - Autocar Professional
Parsons Corporation Stock Analysis and ForecastFree Stock Movement Tracking - Autocar Professional
What drives Rapid7 Inc. stock priceFree Predictions - jammulinksnews.com
Is Pearl Diver Credit Company Inc. a good long term investmentHigh-octane financial growth - jammulinksnews.com
Best Indian Stocks for 5G Investments Exclusive Stock Market PredictionsUnmatched market performance - jammulinksnews.com
KalVista Pharmaceuticals Inc. Stock Analysis and ForecastFree Daily Trading Room Entry - jammulinksnews.com
What makes Bluejay Diagnostics Inc. stock price move sharplyBig Profit Small Risk Alerts - Newser
Why Bluejay Diagnostics Inc. stock attracts strong analyst attention200 Percent Watchlist - Newser
How Bluejay Diagnostics Inc. stock performs during market volatilitySmall Risk Large Return Trades - Newser
Bluejay Diagnostics (NASDAQ:BJDX) Trading Up 1.3% – What’s Next? - Defense World
Is Bluejay Diagnostics, Inc. technically bullish or bearish? - MarketsMojo
Bluejay Diagnostics (BJDX) Stock Skyrockets Over 44% on Nasdaq in Explosive Short-Term Rally - Daily Chhattisgarh News
Why Rent the Runway Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket - Benzinga
Bluejay Diagnostics Initiates SYMON-II Clinical Study - TipRanks
Bluejay Diagnostics advances sepsis test, plans FDA filing By Investing.com - Investing.com South Africa
Bluejay Diagnostics (BJDX) Provides 2025 Mid-Year Business Updat - GuruFocus
Bluejay Diagnostics (BJDX) Provides 2025 Mid-Year Business Update | BJDX Stock News - GuruFocus
Bluejay Diagnostics advances sepsis test, plans FDA filing - Investing.com Australia
Bluejay Diagnostics Provides Mid-Year Business And Corporate Update - MarketScreener
Bluejay Diagnostics Slashes Workforce to Just 5 Employees as Cash Burns, Despite Promising Sepsis Trial Data - Stock Titan
Bluejay Diagnostics (NASDAQ:BJDX) Stock Price Up 1.2% – Here’s Why - Defense World
Bluejay Diagnostics announces CTO departure By Investing.com - Investing.com South Africa
Bluejay Diagnostics Announces CTO Departure Effective May 30 - TipRanks
Bluejay Diagnostics announces CTO departure - Investing.com Australia
Pre-market Movers: IXHL, KLRS, HCTI, DOCS... - RTTNews
Bluejay Diagnostics, Inc. SEC 10-Q Report - TradingView
Bluejay Diagnostics Inc (BJDX) Stock: A Comprehensive 52-Week Review - investchronicle.com
Bluejay Diagnostics Inc (BJDX)’s stock price range in the last year - uspostnews.com
Bluejay Diagnostics Soars 10.47% on Investor Confidence - AInvest
BJDX stock touches 52-week low at $1.6 amid steep annual decline - Investing.com Canada
Bluejay Diagnostics Inc Stock (BJDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):